In the pharmacokinetic study of Ad04 for the treatment of alcohol use disorder, the first patient in Adial Pharmaceuticals reached an important milestone by taking the drug.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.